Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CSL Behring
Pharma
ASH: CSL proves 5-year durability of Hemgenix
After five years of follow-up on its Hemgenix, CSL found that a one-time dose can cut down on annualized bleeding rates by 90% by year five.
Zoey Becker
Dec 7, 2025 12:00pm
CSL earmarks $1.5B for US production expansion over next 5 years
Nov 18, 2025 7:56am
CSL Behring's first commercial pitches Hizentra for PI patients
May 21, 2025 4:10pm
As Pfizer bows out, CSL keeps hemophilia gene therapy hopes alive
Apr 11, 2025 10:32am
China cuts, CSL site closure and Kyowa deal—Fierce Pharma Asia
Nov 22, 2024 3:00am
CSL Behring cuts headcount by 65 at Illinois plant
Apr 15, 2024 1:08pm
